170 related articles for article (PubMed ID: 18378708)
1. Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus.
Cotroneo N; Harris R; Perlmutter N; Beveridge T; Silverman JA
Antimicrob Agents Chemother; 2008 Jun; 52(6):2223-5. PubMed ID: 18378708
[TBL] [Abstract][Full Text] [Related]
2. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus.
Silverman JA; Perlmutter NG; Shapiro HM
Antimicrob Agents Chemother; 2003 Aug; 47(8):2538-44. PubMed ID: 12878516
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial effect of Magnolia officinalis extract against Staphylococcus aureus.
Hu Y; Qiao J; Zhang X; Ge C
J Sci Food Agric; 2011 Apr; 91(6):1050-6. PubMed ID: 21384366
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin exerts rapid bactericidal activity against Bacillus anthracis without disrupting membrane integrity.
Xing YH; Wang W; Dai SQ; Liu TY; Tan JJ; Qu GL; Li YX; Ling Y; Liu G; Fu XQ; Chen HP
Acta Pharmacol Sin; 2014 Feb; 35(2):211-8. PubMed ID: 24362329
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
Holmes RL; Jorgensen JH
Antimicrob Agents Chemother; 2008 Feb; 52(2):757-60. PubMed ID: 18039923
[TBL] [Abstract][Full Text] [Related]
6. Cellular effects induced by Inula graveolens and Santolina corsica essential oils on Staphylococcus aureus.
Guinoiseau E; Luciani A; Rossi PG; Quilichini Y; Ternengo S; Bradesi P; Berti L
Eur J Clin Microbiol Infect Dis; 2010 Jul; 29(7):873-9. PubMed ID: 20490884
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
8. Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus.
Hayden MK; Rezai K; Hayes RA; Lolans K; Quinn JP; Weinstein RA
J Clin Microbiol; 2005 Oct; 43(10):5285-7. PubMed ID: 16207998
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
Begic D; von Eiff C; Tsuji BT
J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
Smith JR; Arya A; Yim J; Barber KE; Hallesy J; Singh NB; Rybak MJ
Antimicrob Agents Chemother; 2016 Jul; 60(7):3970-5. PubMed ID: 27090172
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of daptomycin and comparator agents against Staphylococcus aureus isolates from intravenous drug users with right endocarditis.
Sanchez-Porto A; Casanova-Roman M; Casas-Ciria J; Santaella MJ; Sanchez-Morenilla I; Eiros-Bouza JM
Infez Med; 2010 Jun; 18(2):108-12. PubMed ID: 20610933
[TBL] [Abstract][Full Text] [Related]
12. In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis.
Laganas V; Alder J; Silverman JA
Antimicrob Agents Chemother; 2003 Aug; 47(8):2682-4. PubMed ID: 12878541
[TBL] [Abstract][Full Text] [Related]
13. Daptomycin Resistance and Tolerance Due to Loss of Function in Staphylococcus aureus
Barros EM; Martin MJ; Selleck EM; Lebreton F; Sampaio JLM; Gilmore MS
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397055
[TBL] [Abstract][Full Text] [Related]
14. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin.
Sakoulas G; Alder J; Thauvin-Eliopoulos C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2006 Apr; 50(4):1581-5. PubMed ID: 16569891
[TBL] [Abstract][Full Text] [Related]
15. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
Pillai SK; Wennersten C; Venkataraman L; Eliopoulos GM; Moellering RC; Karchmer AW
Clin Infect Dis; 2009 Oct; 49(8):1169-74. PubMed ID: 19769538
[TBL] [Abstract][Full Text] [Related]
16. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Sader HS; Fritsche TR; Jones RN
Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of resistance to daptomycin in Staphylococcus aureus.
Gómez Casanova N; Siller Ruiz M; Muñoz Bellido JL
Rev Esp Quimioter; 2017 Dec; 30(6):391-396. PubMed ID: 29082727
[TBL] [Abstract][Full Text] [Related]
18. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
Vikram HR; Havill NL; Koeth LM; Boyce JM
J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years.
Appleman MD; Citron DM
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):441-4. PubMed ID: 20226335
[TBL] [Abstract][Full Text] [Related]
20. Impact of Bacterial Membrane Fatty Acid Composition on the Failure of Daptomycin To Kill Staphylococcus aureus.
Boudjemaa R; Cabriel C; Dubois-Brissonnet F; Bourg N; Dupuis G; Gruss A; Lévêque-Fort S; Briandet R; Fontaine-Aupart MP; Steenkeste K
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29735564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
